Fithian’s Idexx Laboratories IDXX Stock Holding History

Fithian’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$8.91M	Buy	17,809 +7,519	+73%	+$3.6M	18.61%	1
2022 Q4	$4.2M	Buy	+10,290	New	+$3.99M	19.95%	1

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fithian's IDXX Position: Q1 2023 in Review

Fithian increased its Idexx Laboratories (IDXX) stake by 73% in Q1 2023, buying an estimated $3.6M and bringing the position to 17,809 shares worth $8.91M. The position accounts for 18.61% of the portfolio, ranked #1.

Fithian first reported a position in IDXX in Q4 2022 and has held it in 2 quarters since. 1,056 funds tracked by Wall St. Rank hold IDXX as of Q1 2023.

Fithian held 17,809 shares of Idexx Laboratories worth $8.91M as of Q1 2023.
Fithian bought 7,519 Idexx Laboratories shares in Q1 2023, an estimated $3.6M.
Idexx Laboratories made up 18.61% of Fithian's portfolio in Q1 2023, its #1 holding.
Fithian first reported a position in Idexx Laboratories in Q4 2022 and has held it in 2 quarters since.
1,056 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2023.

Based on Fithian's 13F filing for Q1 2023, filed 3 May 2023.